1. Home
  2. BHE vs ALMR Comparison

BHE vs ALMR Comparison

Compare BHE & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benchmark Electronics Inc.

BHE

Benchmark Electronics Inc.

N/A

Current Price

$74.44

Market Cap

2.6B

Sector

Technology

ML Signal

N/A

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$28.68

Market Cap

2.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BHE
ALMR
Founded
1979
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
BHE
ALMR
Price
$74.44
$28.68
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$55.00
N/A
AVG Volume (30 Days)
292.4K
280.1K
Earning Date
04-29-2026
N/A
Dividend Yield
0.94%
N/A
EPS Growth
N/A
N/A
EPS
0.91
N/A
Revenue
$2,659,108,000.00
N/A
Revenue This Year
$7.03
N/A
Revenue Next Year
$6.57
N/A
P/E Ratio
$79.81
N/A
Revenue Growth
0.11
N/A
52 Week Low
$35.97
$21.58
52 Week High
$100.41
$38.54

Technical Indicators

Market Signals
Indicator
BHE
ALMR
Relative Strength Index (RSI) 44.22 45.39
Support Level $72.31 $23.69
Resistance Level $86.86 $29.06
Average True Range (ATR) 2.12 1.91
MACD 0.52 -0.59
Stochastic Oscillator 43.00 19.40

Price Performance

Historical Comparison
BHE
ALMR

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia, and Europe, of which key revenue is derived from the Americas.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: